SFM
ASBPW

Spartan Fund Management’s Aspire Biopharma Warrant ASBPW Stock Holding History

Spartan Fund Management’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-187,080
Closed -$11.2K – 151
2023
Q4 		$11.2K Hold
187,080
– – 0.01% 114
2023
Q3 		$9.35K Sell
187,080
-1,804
-1% -$146 0.01% 168
2023
Q2 		$18.7K Buy
188,884
+1,804
+1% +$66 ﹤0.01% 217
2023
Q1 		$7.82K Buy
187,080
+142,486
+320% +$9.42K ﹤0.01% 254
2022
Q4 		$4K Hold
44,594
– – ﹤0.01% 327
2022
Q3 		$5K Buy
+44,594
New +$6.49K ﹤0.01% 371

Other funds holding ASBPW

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Spartan Fund Management's ASBPW Position: Q1 2024 in Review

Spartan Fund Management sold out of Aspire Biopharma Warrant (ASBPW) in Q1 2024, closing a stake of 187,080 shares — an estimated $11.2K sold.

Spartan Fund Management first reported a position in ASBPW in Q3 2022 and held it in 6 quarters. The position peaked at $18.7K in Q2 2023. 34 funds tracked by Wall St. Rank hold ASBPW as of Q1 2024.

  • Spartan Fund Management reported no remaining Aspire Biopharma Warrant position as of Q1 2024 after selling out during the quarter.
  • Spartan Fund Management sold 187,080 Aspire Biopharma Warrant shares in Q1 2024, an estimated $11.2K.
  • Spartan Fund Management first reported a position in Aspire Biopharma Warrant in Q3 2022 and held it in 6 quarters.
  • Spartan Fund Management's Aspire Biopharma Warrant position peaked at $18.7K in Q2 2023.
  • 34 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q1 2024.

Based on Spartan Fund Management's 13F filing for Q1 2024, filed 23 Apr 2024.